Eight biopharmaceutical and CXO companies gathered at the performance briefing meeting of the Sci-Tech Innovation Board, breaking through key technological bottlenecks in the field, becoming the focus of interaction.

On September 15th, the industry performance briefing session for the biopharmaceuticals and CXO industries of the Science and Technology Innovation Board was held. Eight companies including Betta Pharmaceuticals, Jabez International, Shineon Pharmaceutical, Haohai Biological appeared to respond to investors' concerns in the form of online interactive Q&A, clarifying the industry ecology and development trends. It is worth noting that amid the current prosperity of the biopharmaceutical industry, the research and development progress and global market layout of related companies are receiving much attention. Thanks to the high intensity of research and development investment, the participating companies are also full of confidence in the development of the second half of the year.